GeneDx Holdings (WGS) Assets Average (2020 - 2026)
GeneDx Holdings' (WGS) quarterly Assets Average came in at $493.9 million in Q2 2026, up 8.51% year-over-year from $455.1 million in Q2 2025, and down 4.1% quarter-over-quarter from $515.0 million in Q1 2026.
Analysis
GeneDx Holdings (WGS) Assets Average (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Assets Average for 7 consecutive years, with $493.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average rose 8.51% year-over-year to $493.9 million in Q2 2026; TTM through Jun 2026 was $493.9 million, a 8.51% increase from a year earlier, with the FY2025 full-year figure at $471.5 million, up 12.52% from the prior year.
- Assets Average was $493.9 million for Q2 2026 at GeneDx Holdings, down from $515.0 million in the prior quarter.
- Over five years, Assets Average peaked at $881.1 million in Q3 2022 and troughed at $391.8 million in Q2 2024.
- A 5-year average of $510.7 million and a median of $486.4 million in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 267.49% in 2022 and sank 49.29% in 2023, its largest moves.
- Over 5 years, Assets Average stood at $660.0 million in 2022, then slumped by 36.66% to $418.0 million in 2023, then declined by 0.94% to $414.1 million in 2024, then rose by 22.87% to $508.8 million in 2025, then slipped by 2.93% to $493.9 million in 2026.
- The last three Assets Average figures came in at $493.9 million (Q2 2026), $515.0 million (Q1 2026), and $508.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 2.64 Bn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 16.81 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 18.81 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 1.91 Bn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 2.25 Bn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 1.20 Bn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 3.27 Bn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 715.21 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 573.31 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 493.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 493.89 Mn |
| Mar 31, 2026 | 515.01 Mn |
| Dec 31, 2025 | 508.81 Mn |
| Sep 30, 2025 | 478.88 Mn |
| Jun 30, 2025 | 455.15 Mn |
| Mar 31, 2025 | 432.91 Mn |
| Dec 31, 2024 | 414.11 Mn |
| Sep 30, 2024 | 398.97 Mn |
| Jun 30, 2024 | 391.81 Mn |
| Mar 31, 2024 | 406.64 Mn |
| Dec 31, 2023 | 418.02 Mn |
| Sep 30, 2023 | 446.84 Mn |
| Jun 30, 2023 | 510.84 Mn |
| Mar 31, 2023 | 518.12 Mn |
| Dec 31, 2022 | 659.96 Mn |
| Sep 30, 2022 | 881.13 Mn |
| Jun 30, 2022 | 725.48 Mn |
| Mar 31, 2022 | 535.88 Mn |
| Dec 31, 2021 | 578.73 Mn |
| Sep 30, 2021 | 389.45 Mn |